Landmark Cancer Center is a standalone oncology practice in Oklahoma City offering medical oncology, hematology, and infusion services, with chemotherapy and immunotherapy administered in a dedicated infusion suite rather than at a hospital facility. The practice handles adult cancer care across common solid tumors and blood disorders without requiring referral to a hospital system or distant treatment center.
Landmark operates as a private oncology practice—independent from Oklahoma City's hospital systems (OU Health and Mercy). Patients receive chemotherapy, targeted therapy, and immunotherapy infusions on-site in a clinical setting, then follow up with the same medical oncologist for monitoring and treatment adjustments. This structure means visits for infusion and medical assessment happen at one location rather than being split between a hospital cancer center and an oncologist's office. The practice employs board-certified medical oncologists and hematologists and maintains its own laboratory for rapid test results between appointments.
Landmark provides medical oncology consultation and treatment planning, chemotherapy and immunotherapy infusion, hormone therapy, supportive care (anti-nausea, pain management), phlebotomy and on-site lab work, and hematology services for blood cancers and clotting disorders. Infusion appointments typically run 2 to 4 hours depending on the drug regimen; patients are seated in a reclining chair in the infusion suite and may bring a companion. Consultation fees and treatment costs are billed through insurance or private pay; the practice accepts Medicare, most major commercial insurers, and Medicaid, though coverage and patient responsibility vary by plan. Request an estimate from the practice's billing department before beginning treatment; chemotherapy drug costs and infusion facility charges fluctuate based on drug supply and insurance formulary status. Many patients with cancer-related financial hardship qualify for manufacturer copay assistance programs, which Landmark's financial counselors can help identify.
Oklahoma City's oncology care splits between hospital-based cancer centers and independent practices. OU Health's Stephenson Cancer Center (affiliated with the University of Oklahoma) is Oklahoma City's largest cancer program and operates multiple clinic locations plus inpatient beds; it handles complex cases, clinical trials, and second opinions, but appointments often require weeks of wait time and patients rotate through residents and fellows in addition to attending oncologists. Mercy Hospital operates its own cancer services through Mercy Cancer Institute with infusion capacity on-site; it serves patients in the southwest and central parts of Oklahoma City but requires treatment within the Mercy system. Landmark suits patients seeking faster appointment availability, consistent continuity with a single medical oncologist, and infusion in a smaller, quieter setting than a large hospital cancer center. Choose Landmark if your oncology needs are straightforward (standard chemotherapy, hormone therapy, or hematology without complex complications) and you value quick access and a private practice environment. Choose OU Health's Stephenson Center if you have a rare cancer type, need second-opinion evaluation by a subspecialist, want access to clinical trials, or require hospital admission. Choose Mercy if you live on the southwest side and prefer integrated care within one health system.
Landmark is the right fit for newly diagnosed patients with common cancers (breast, lung, colon, prostate, lymphoma) who need timely treatment initiation; patients already under care who want to switch to a practice with shorter wait times; and patients with hematologic disorders (leukemia, lymphoma, myeloma) or clotting disorders who benefit from focused blood cancer expertise. The practice works well for those with commercial insurance or Medicare, since infusion and oncology services are fully billable. It does not suit patients requiring inpatient chemotherapy, stem cell transplantation, or admission for severe side effects (those cases go to a hospital); patients enrolled in clinical trials at academic medical centers; or uninsured patients seeking free or low-cost clinic care (Landmark does not operate a charitable clinic and expects private pay or insurance). Patients with multiple complex medical conditions managed by specialists may find the hospital cancer center's integrated approach more convenient.
Call to schedule an initial consultation; appointment availability is typically within 1 to 2 weeks. Bring insurance cards, photo ID, and any prior imaging (CT, MRI, PET scans on disk or available through your prior provider's records). The oncologist will take a detailed history, review pathology reports and imaging, perform a physical exam, and discuss treatment options. Lab work (blood counts, metabolic panel, tumor markers) is drawn the same day in-house. The oncologist will outline the treatment plan, timeline, expected side effects, and financial obligations. A nurse will review infusion logistics, port placement (if needed), and supportive care medications. Plan for the first visit to last 45 minutes to 1.5 hours.
Landmark operates Monday through Friday, 8 a.m. to 5 p.m., with limited Saturday hours available for infusion appointments; verify current Saturday availability by calling ahead. The practice is located in a standalone building with dedicated parking; no parking permits or fees are required. If you require port placement for infusion, Landmark can arrange that at an ambulatory surgery center or coordinate with a hospital vascular lab. Public transportation in Oklahoma City is limited; a car is essential for regular appointments. Confirm specific hours with the practice directly, as infusion clinic hours may extend beyond office visit hours.
Landmark's independence from Oklahoma City's hospital systems gives patients an alternative to long waits at Stephenson Cancer Center while maintaining full oncology and infusion services in a single location. For patients with straightforward cancer diagnoses and a preference for continuity, this practice eliminates the logistical fragmentation of hospital-based oncology.
